Concepedia

Gerrit Klaerner

GK

6

Publications

280

Citations

6

H-Index

2017

Active since

Affiliations

University of Rochester(Current)

University of Manitoba

Walker (United States)

Baylor Scott & White Health

University College London

Gerrit Klaerner is an author at University of Rochester specializing in metabolic syndrome, urology, and metabolic acidosis.

Top concepts

Publications per year

2017–2024

6

Publications

6

Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension

Donald E. Wesson, Vandana Mathur, Navdeep Tangri et al. · The Lancet · 2019 · 87 citations

, , +9

Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial

Donald E. Wesson, Vandana Mathur, Navdeep Tangri et al. · The Lancet · 2019 · 84 citations

, , +8

Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD

David A. Bushinsky, Thomas H. Hostetter, Gerrit Klaerner et al. · Clinical Journal of the American Society of Nephrology · 2017 · 67 citations · Full text

Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease

Gerrit Klaerner, Jun Shao, Kalpesh Biyani et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 16 citations · Full text

VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis

Navdeep Tangri, Vandana Mathur, David A. Bushinsky et al. · Journal of the American Society of Nephrology · 2024 · 15 citations · Full text

Rows per page

1–5 of 6